NICM
RVNC

Neo Ivy Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Neo Ivy Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,952
Closed -$606K – 480
2023
Q2 		$606K Buy
+23,952
New +$606K 0.32% 113